TWST · Twist Bioscience Corp · Earnings Call Transcripts & Audio
Market Cap
$7.97B
Shares
62.71M
Twist Bioscience Corp Earnings Call Transcripts
Quarterly earnings calls for Twist Bioscience Corp (TWST), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲51%
$57.31M
−$51.12M
'22 Q4
22-11-18
▲29.1%
$54.24M
−$41.82M
'23 Q1
23-02-03
▲25%
$60.18M
−$59.16M
'23 Q2
23-05-05
▲13.6%
$63.74M
−$57.40M
'23 Q3
23-08-04
▲16.8%
$66.95M
−$46.24M
'23 Q4
23-11-17
▲31.8%
$71.50M
−$43.01M
'24 Q1
24-02-02
▲25.1%
$75.30M
−$45.49M
'24 Q2
24-05-02
▲27.8%
$81.46M
−$85.57M
'24 Q3
24-08-02
▲26.5%
$84.71M
−$34.66M
'24 Q4
24-11-18
▲24.1%
$88.71M
−$31.59M
'25 Q1
25-02-03
▲23.2%
$92.79M
−$39.33M
'25 Q2
25-05-05
▲17.9%
$96.06M
$20.39M
'25 Q3
25-08-04
▲16.9%
$99.01M
−$27.14M
'25 Q4
25-11-14
▲16.9%
$103.70M
−$30.51M
'26 Q1
26-02-02
▲19.3%
$110.72M
−$44.02M
'26 Q2
26-05-04
LATEST
▲23.2%
$118.38M
−$35.05M
'26 Q3
26-08-03
Conference
Investor event
2026-09-15
Twist Bioscience Corp (TWST) September 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-08-03
Twist Bioscience Corp (TWST) Q3 2026 Earnings Call Transcript
Confident tone
Capacity expansion / supply
AI-enabled drug discovery
Competitive positioning vs. GenScript and others
Revenue
$118.38M
▲ 23.2% YoY Diluted EPS
$-0.56
▼ 269.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-02
Twist Bioscience Corp (TWST) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Capital Markets Day
Investor event
2026-05-21
Twist Bioscience Corp (TWST) May 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-05-04
Twist Bioscience Corp (TWST) Q2 2026 Earnings Call Transcript
Confident tone
NGS and oncology diagnostics
Path to adjusted EBITDA breakeven
DNA synthesis and Protein Solutions growth
Revenue
$110.72M
▲ 19.3% YoY Diluted EPS
$-0.71
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-02-17
Twist Bioscience Corp (TWST) February 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-02-02
Twist Bioscience Corp (TWST) Q1 2026 Earnings Call Transcript
Confident tone
NGS and diagnostic partnerships
Gross margin and SAM expansion
DNA synthesis platform and NPI engine
Revenue
$103.70M
▲ 16.9% YoY Diluted EPS
$-0.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-11-14
Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Transcript
Positive tone
NGS and MRD
Segment realignment (DNA Synthesis and Protein Solutions)
Gross margin improvement
Revenue
$99.01M*
▲ 16.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-04
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Transcript
Confident tone
Financial Performance and Records
NGS / Diagnostics Growth
Gross Margin Expansion and Path to Profitability
Revenue
$96.06M
▲ 17.9% YoY Diluted EPS
$0.33
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-05
Twist Bioscience Corp (TWST) Q2 2025 Earnings Call Transcript
Confident tone
Revenue Growth and Records
NGS and AgBio Expansion
US Academic Market and Policy Environment
Revenue
$92.79M
▲ 23.2% YoY Diluted EPS
$-0.66
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-02-03
Twist Bioscience Corp (TWST) Q1 2025 Earnings Call Transcript
Confident tone
NGS and Liquid Biopsy
Gross Margin Expansion
Revenue Growth and Beat
Revenue
$88.71M
▲ 24.1% YoY Diluted EPS
$-0.53
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-11-18
Twist Bioscience Corp (TWST) Q4 2024 Earnings Call Transcript
Confident tone
NGS / MRD growth
Biopharma segment traction
Gross margin expansion and path to adjusted EBITDA breakeven
Revenue
$84.71M*
▲ 26.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-08-02
Twist Bioscience Corp (TWST) Q3 2024 Earnings Call Transcript
Confident tone
Revenue Growth and Financial Performance
NGS and Clinical Markets
SynBio and Express Genes
Revenue
$81.46M
▲ 27.8% YoY Diluted EPS
$-1.47
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-02
Twist Bioscience Corp (TWST) Q2 2024 Earnings Call Transcript
Confident tone
Express Genes product launch and growth
NGS revenue and clinical customers
Gross margin expansion toward profitability
Revenue
$75.30M
▲ 25.1% YoY Diluted EPS
$-0.79
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-02-02
Twist Bioscience Corp (TWST) Q1 2024 Earnings Call Transcript
Confident tone
NGS market expansion and customer wins
Path to profitability and margin expansion
Revenue growth and record quarter
Revenue
$71.50M
▲ 31.8% YoY Diluted EPS
$-0.75
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-11-17
Twist Bioscience Corp (TWST) Q4 2023 Earnings Call Transcript
Revenue
$66.95M*
▲ 16.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-08-04
Twist Bioscience Corp (TWST) Q3 2023 Earnings Call Transcript
Revenue
$63.74M
▲ 13.6% YoY Diluted EPS
$-1.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-05-05
Twist Bioscience Corp (TWST) Q2 2023 Earnings Call Transcript
Revenue
$60.18M
▲ 25% YoY Diluted EPS
$-1.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-02-03
Twist Bioscience Corp (TWST) Q1 2023 Earnings Call Transcript
Revenue
$54.24M
▲ 29.1% YoY Diluted EPS
$-0.74
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-11-18
Twist Bioscience Corp (TWST) Q4 2022 Earnings Call Transcript
Revenue
$57.31M*
▲ 51% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-08-05
Twist Bioscience Corp (TWST) Q3 2022 Earnings Call Transcript
Revenue
$56.11M
▲ 60.2% YoY Diluted EPS
$-1.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-05-05
Twist Bioscience Corp (TWST) Q2 2022 Earnings Call Transcript
Revenue
$48.13M
▲ 54.2% YoY Diluted EPS
$-1.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-02-04
Twist Bioscience Corp (TWST) Q1 2022 Earnings Call Transcript
Revenue
$42.02M
▲ 49.2% YoY Diluted EPS
$-0.91
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-11-22
Twist Bioscience Corp (TWST) Q4 2021 Earnings Call Transcript
Revenue
$37.95M*
▲ 17% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-08-06
Twist Bioscience Corp (TWST) Q3 2021 Earnings Call Transcript
Revenue
$35.02M
▲ 65.1% YoY Diluted EPS
$-0.82
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-05-06
Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
Revenue
$31.20M
▲ 61.7% YoY Diluted EPS
$-0.78
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-02-04
Twist Bioscience Corp (TWST) Q1 2021 Earnings Call Transcript
Revenue
$28.16M
▲ 64.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-11-23
Twist Bioscience Corp (TWST) Q4 2020 Earnings Call Transcript
Revenue
$32.43M*
▲ 106.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-08-06
Twist Bioscience Corp (TWST) Q3 2020 Earnings Call Transcript
Revenue
$21.21M
▲ 55.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-05-07
Twist Bioscience Corp (TWST) Q2 2020 Earnings Call Transcript
Revenue
$19.30M
▲ 42.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-02-06
Twist Bioscience Corp (TWST) Q1 2020 Earnings Call Transcript
Revenue
$17.16M
▲ 49.4% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Showing 1–31 of 31 earnings calls
Key facts
CIK
1581280
CUSIP
90184D100
13F (30d)
155 filings
154 filers
Visit website
Investor relations